Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema
- 8 November 2016
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 124 (1), 74-81
- https://doi.org/10.1016/j.ophtha.2016.09.021
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaThe New England Journal of Medicine, 2015
- Prevalence of and Risk Factors for Diabetic Macular Edema in the United StatesJAMA Ophthalmology, 2014
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial ResultsOphthalmology, 2014
- Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular EdemaOphthalmology, 2014
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III TrialsOphthalmology, 2013
- Retinal Thickness in People with Diabetes and Minimal or No Diabetic Retinopathy: Heidelberg Spectralis Optical Coherence TomographyInvestigative Ophthalmology & Visual Science, 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012
- Clinical Evaluation and Treatment Accuracy in Diabetic Macular Edema Using Navigated Laser Photocoagulator NAVILASOphthalmology, 2011
- Macular Thickness Measurements in Healthy Eyes Using Six Different Optical Coherence Tomography InstrumentsInvestigative Ophthalmology & Visual Science, 2009
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994